
Surgalign Holdings, Inc. – NASDAQ:SRGA
Surgalign Holdings stock price monthly change
Surgalign Holdings stock price quarterly change
Surgalign Holdings stock price yearly change
Surgalign Holdings key metrics
Market Cap | N/A |
Enterprise value | 2.28M |
P/E | -0.17 |
EV/Sales | 0.01 |
EV/EBITDA | -0.04 |
Price/Sales | 0.06 |
Price/Book | -0.32 |
PEG ratio | N/A |
EPS | -7.58 |
Revenue | 78.12M |
EBITDA | -66.40M |
Income | -50.48M |
Revenue Q/Q | -18.71% |
Revenue Y/Y | -11.03% |
Profit margin | -48.91% |
Oper. margin | -56.18% |
Gross margin | 55.75% |
EBIT margin | -56.18% |
EBITDA margin | -85.01% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSurgalign Holdings stock price history
Surgalign Holdings stock forecast
Surgalign Holdings financial statements
Jun 2022 | 20.62M | -5.68M | -27.58% |
---|---|---|---|
Sep 2022 | 20.17M | -9.83M | -48.73% |
Dec 2022 | 20.57M | -39.11M | -190.11% |
Mar 2023 | 16.74M | 4.14M | 24.75% |
2023-08-08 | 0.27 | -2.05 |
---|
Jun 2022 | 105697000 | 84.86M | 80.29% |
---|---|---|---|
Sep 2022 | 88043000 | 75.66M | 85.94% |
Dec 2022 | 70242000 | 95.97M | 136.63% |
Mar 2023 | 67712000 | 86.64M | 127.96% |
Jun 2022 | -13.27M | -1.87M | 135K |
---|---|---|---|
Sep 2022 | -13.37M | -2.32M | -7K |
Dec 2022 | -6.32M | -1.71M | 10.88M |
Mar 2023 | -9.02M | 15.66M | -19K |
Surgalign Holdings alternative data
Aug 2023 | 217 |
---|---|
Sep 2023 | 217 |
Oct 2023 | 217 |
Nov 2023 | 217 |
Dec 2023 | 217 |
Jan 2024 | 217 |
Feb 2024 | 217 |
Mar 2024 | 217 |
Apr 2024 | 217 |
May 2024 | 217 |
Jun 2024 | 217 |
Jul 2024 | 217 |
Surgalign Holdings other data
Period | Buy | Sel |
---|---|---|
Aug 2021 | 450745 | 0 |
Feb 2022 | 1238806 | 0 |
May 2022 | 19000 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | LYLE DAVID officer: Chief Financial Officer | Common Stock | 19,000 | $5.26 | $99,921 | ||
Purchase | THUNANDER CHRISTOPHER officer: Chief Accounting Officer | Warrants (right to buy) | 97,500 | $0.6 | $58,500 | ||
Purchase | RICH TERRY M. director, officer.. | Warrants (right to buy) | 326,088 | $0.6 | $195,653 | ||
Purchase | RICH TERRY M. director, officer.. | Common Stock | 434,784 | $0.46 | $200,001 | ||
Purchase | DURALL WILLIAM SCOTT officer: Chief Co.. | Warrant (right to buy) | 163,043 | $0.6 | $97,826 | ||
Purchase | DURALL WILLIAM SCOTT officer: Chief Co.. | Common Stock | 217,391 | $0.46 | $100,000 | ||
Purchase | MCEACHIN THOMAS director | Common Stock | 20,000 | $1.03 | $20,600 | ||
Purchase | RICH TERRY M. director, officer.. | Common Stock | 10,100 | $0.91 | $9,191 | ||
Purchase | VALERIANI NICHOLAS J director | Common Stock | 55,000 | $0.95 | $52,250 | ||
Purchase | RICH TERRY M. director, officer.. | Common Stock | 365,645 | $0.94 | $343,706 |
Quarter | Transcript |
---|---|
Q1 2023 11 May 2023 | Q1 2023 Earnings Call Transcript |
Q4 2022 30 Mar 2023 | Q4 2022 Earnings Call Transcript |
Q3 2022 2 Nov 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 9 Aug 2022 | Q2 2022 Earnings Call Transcript |
-
When is Surgalign Holdings's next earnings date?
Unfortunately, Surgalign Holdings's (SRGA) next earnings date is currently unknown.
-
Does Surgalign Holdings pay dividends?
No, Surgalign Holdings does not pay dividends.
-
What is Surgalign Holdings's stock symbol?
Surgalign Holdings, Inc. is traded on the NASDAQ under the ticker symbol "SRGA".
-
What is Surgalign Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Surgalign Holdings?
Shares of Surgalign Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Surgalign Holdings's key executives?
Surgalign Holdings's management team includes the following people:
- Mr. Joshua H. DeRienzis Chief Legal Officer & Corporation Sec.(age: 56, pay: $833,520)
- Mr. Terry M. Rich Pres, Chief Executive Officer & Director(age: 57, pay: $646,350)
- Mr. William Scott Durall Chief Commercial Officer(age: 61, pay: $373,200)
-
How many employees does Surgalign Holdings have?
As Jul 2024, Surgalign Holdings employs 217 workers.
-
When Surgalign Holdings went public?
Surgalign Holdings, Inc. is publicly traded company for more then 25 years since IPO on 11 Aug 2000.
-
What is Surgalign Holdings's official website?
The official website for Surgalign Holdings is surgalign.com.
-
Where are Surgalign Holdings's headquarters?
Surgalign Holdings is headquartered at 520 Lake Cook Road, Deerfield, IL.
-
How can i contact Surgalign Holdings?
Surgalign Holdings's mailing address is 520 Lake Cook Road, Deerfield, IL and company can be reached via phone at +224 3034651.
Surgalign Holdings company profile:

Surgalign Holdings, Inc.
surgalign.comNASDAQ
217
Medical - Devices
Healthcare
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Deerfield, IL 60015
CIK: 0001760173
ISIN: US86882C2044
CUSIP: 86882C204